Replace animal-derived antivenom with broadly-neutralizing recombinant human antibody cocktails

Manufacture antivenom as a defined cocktail of recombinant human monoclonal antibodies targeting conserved toxin families (3FTx, PLA2, SVMP, SVSP), replacing dozens of narrow regional polyclonal sera with a small number of broad-spectrum products split roughly by neurotoxic-elapi